Logo Logo
Hilfe
Hilfe
Switch Language to English

Tokarew, Nicholas J.A.; Gosálvez, Javier Suárez; Nottebrock, Alessia; Briukhovestka, Daria; Endres, Stefan ORCID logoORCID: https://orcid.org/0000-0002-4703-537X; Cadilha, Bruno L. und Kobold, Sebastian ORCID logoORCID: https://orcid.org/0000-0002-5612-4673 (2022): Flow cytometry detection and quantification of CAR T cells into solid tumors. In: Methods in Cell Biology, Bd. 167: S. 99-122

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Adoptive T cell therapy (ACT) is a therapeutic approach which employs genetically manipulated autologous T cells to target and eliminate a patient's malignancy. This novel therapeutic approach, when employing a chimeric antigen receptor (CAR) targeting CD19-expressing B cells, has shown remarkable success in treating acute B-cell lymphocytic leukemia. However, blood born malignancies represent only a fraction of cancers which affect patients. Unfortunately, the utilization of ACT to target solid malignancies has only shown marginal success rates. There are many known obstacles which hinder CAR T cell therapy in patients suffering from solid cancer, one notable obstacle is the effective trafficking of CAR T cells to the tumor site. With the rapid advancement of novel approaches and targets which may enhance CAR T cell infiltration into solid tumors, a standardized approach to assess and measure CAR T cell infiltration becomes imperative in order to compare these different approaches across platforms. Here we describe a flow cytometry method which enables the rapid detection and quantification of CAR T cells which have reached and entered the tumor mass following intravenous injection. Competence with single cell preparation and flow cytometry is required for optimal results.

Dokument bearbeiten Dokument bearbeiten